The lymphatic drainage of the human heart, J Anat, vol.63, issue.3, pp.291-313, 1929. ,
The cardiac lymphatics, Ann Surg, vol.171, pp.899-902, 1970. ,
The grossly invisible and generally ignored lymphatics of the mammalian heart, Med Hypotheses, vol.76, pp.604-606, 2011. ,
Microvascular fluid exchange and the revised Starling principle, Cardiovasc Res, vol.87, 2010. ,
Cardiac lymph flow impairment and myocardial fibrosis. Effects of chronic obstruction in dogs, Arch Pathol, vol.76, pp.424-433, 1963. ,
Impairment of left ventricular function by acute cardiac lymphatic obstruction, Cardiovasc Res, vol.33, pp.164-171, 1997. ,
The role of lymphatic vessels in the heart, Pathophysiology, vol.17, pp.307-314, 2010. ,
Myocardial fluid balance, Eur J Cardiothorac Surg, vol.20, pp.1220-1230, 2001. ,
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis, Am J Physiol, vol.270, issue.5, pp.1803-1811, 1996. ,
,
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction, J Clin Invest, vol.113, pp.885-894, 2004. ,
Pathophysiological consequences of VEGFinduced vascular permeability, Nature, vol.437, pp.497-504, 2005. ,
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J Exp Med, vol.204, pp.3037-3047, 2007. ,
Role of M2-like macrophage recruitment during angiogenic growth factor therapy, Angiogenesis, vol.18, pp.191-200, 2015. ,
Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ Res, vol.91, pp.988-998, 2002. ,
Reactive oxygen metabolites inhibit spontaneous lymphatic contractions, Am J Physiol, vol.260, issue.6, pp.1935-1943, 1991. ,
Cytokines are systemic effectors of lymphatic function in acute inflammation, Cytokine, vol.64, pp.362-369, 2013. ,
Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging, Heart, vol.85, pp.639-642, 2001. ,
Cardiac magnetic resonance demonstrates myocardial oedema in remote tissue early after reperfused myocardial infarction, Arch Cardiovasc Dis, vol.102, pp.633-639, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00467140
Molecular mechanisms of lymphangiogenesis in health and disease, Cancer Cell, vol.1, pp.219-227, 2002. ,
The lymphatic vasculature in disease, Nat Med, vol.17, 2011. ,
Lymphangiogenic factors, mechanisms, and applications, J Clin Invest, vol.124, pp.878-887, 2014. ,
Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure, Lymphat Res Biol, vol.7, pp.21-27, 2009. ,
Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions, Eur J Clin Invest, vol.41, pp.487-497, 2010. ,
Biological basis of therapeutic lymphangiogenesis, Circulation, vol.123, pp.1335-1351, 2011. ,
Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation, J Exp Med, vol.207, pp.2255-2269, 2010. ,
Growth factor therapy and autologous lymph node transfer in lymphedema, Circulation, vol.123, pp.613-620, 2011. ,
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, pp.1059-1069, 2011. ,
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004. ,
Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury, Ann Thorac Surg, vol.64, pp.993-998, 1997. ,
Comparative and developmental anatomy of cardiac lymphatics, ScientificWorldJournal, p.183170, 2014. ,
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution, Blood, vol.113, pp.5650-5659, 2009. ,
Immune cells control skin lymphatic electrolyte homeostasis and blood pressure, J Clin Invest, vol.123, pp.2803-2815, 2013. ,
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities, J Biol Chem, vol.273, pp.6599-6602, 1998. ,
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer, Nat Med, vol.14, pp.882-888, 2008. ,
Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts, Circulation, vol.121, pp.1413-1422, 2010. ,
Effects of myocardial edema on the development of myocardial interstitial fibrosis, Microcirculation, vol.7, pp.269-280, 2000. ,
Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice, Circ Res, vol.95, pp.637-644, 2004. ,
An analysis of the function and expression of D6 on lymphatic endothelial cells, Blood, vol.121, pp.3768-3777, 2013. ,
Lymphangiogenesis in myocardial remodelling after infarction, Histopathology, vol.51, pp.345-353, 2007. ,
Reconstitution of myocardial lymphatic vessels after acute infarction of rat heart, Lymphology, vol.45, pp.80-86, 2012. ,
Cardiac lymphatics are heterogeneous in origin and respond to injury, Nature, vol.522, pp.62-67, 2015. ,
Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function, Circ Res, vol.68, pp.1713-1721, 1991. ,
Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function, Cardiovasc Res, vol.87, pp.331-339, 2010. ,
Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells, Am J Pathol, vol.173, pp.1202-1209, 2008. ,
Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation, J Cell Biol, vol.197, pp.837-849, 2012. ,
Flow velocity of cardiac lymph and contractility of the heart: an experimental study, Ann Thorac Surg, vol.23, pp.230-234, 1977. ,
Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function, Am J Physiol, vol.268, issue.1, pp.178-183, 1995. ,
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia, Am J Pathol, vol.153, issue.10, pp.65582-65586, 1998. ,
Phase ½ placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia, Circulation, vol.105, pp.2012-2018, 2002. ,
Proteolytic processing regulates receptor specificity and activity of VEGF-C, EMBO J, vol.16, pp.3898-3911, 1997. ,
Vascular endothelial growth factor C induces angiogenesis in vivo, Proc Natl Acad Sci U S A, vol.95, pp.14389-14394, 1998. ,
Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability, Circ Res, vol.94, pp.664-670, 2004. ,
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation, Nat Med, vol.13, pp.1458-1466, 2007. ,
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, J Exp Med, vol.196, pp.1497-1506, 2002. ,
Therapeutic angiogenesis for ischemic disorders: what is missing for clinical benefits, Discov Med, vol.9, pp.179-184, 2010. ,
Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis, Proc Natl Acad Sci U S A, vol.109, pp.15894-15899, 2012. ,